| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | protein arginylation | 6.23e-06 | 2 | 52 | 2 | GO:0016598 | |
| GeneOntologyBiologicalProcess | territorial aggressive behavior | 1.87e-05 | 3 | 52 | 2 | GO:0002124 | |
| GeneOntologyBiologicalProcess | male courtship behavior | 3.73e-05 | 4 | 52 | 2 | GO:0008049 | |
| GeneOntologyBiologicalProcess | courtship behavior | 1.30e-04 | 7 | 52 | 2 | GO:0007619 | |
| GeneOntologyCellularComponent | symmetric, GABA-ergic, inhibitory synapse | 3.63e-05 | 4 | 52 | 2 | GO:0098983 | |
| Domain | NLGN4 | 7.31e-06 | 2 | 51 | 2 | IPR030025 | |
| Domain | Nlgn | 7.27e-05 | 5 | 51 | 2 | IPR000460 | |
| Domain | Carboxylesterase_B_CS | 5.59e-04 | 13 | 51 | 2 | IPR019819 | |
| Domain | CARBOXYLESTERASE_B_2 | 6.51e-04 | 14 | 51 | 2 | PS00941 | |
| Domain | COesterase | 6.51e-04 | 14 | 51 | 2 | PF00135 | |
| Domain | CarbesteraseB | 6.51e-04 | 14 | 51 | 2 | IPR002018 | |
| Domain | Myosin_head_motor_dom | 4.83e-03 | 38 | 51 | 2 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 4.83e-03 | 38 | 51 | 2 | PS51456 | |
| Domain | Myosin_head | 4.83e-03 | 38 | 51 | 2 | PF00063 | |
| Domain | MYSc | 4.83e-03 | 38 | 51 | 2 | SM00242 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 18434543 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 23183221 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 24855039 | ||
| Pubmed | Sex-specific microglia state in the Neuroligin-4 knock-out mouse model of autism spectrum disorder. | 2.19e-06 | 2 | 52 | 2 | 37001827 | |
| Pubmed | Increased Network Inhibition in the Dentate Gyrus of Adult Neuroligin-4 Knock-Out Mice. | 2.19e-06 | 2 | 52 | 2 | 37080762 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 29106499 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 26456829 | ||
| Pubmed | Nlgn4 knockout induces network hypo-excitability in juvenile mouse somatosensory cortex in vitro. | 2.19e-06 | 2 | 52 | 2 | 24104404 | |
| Pubmed | A Cluster of Autism-Associated Variants on X-Linked NLGN4X Functionally Resemble NLGN4Y. | 2.19e-06 | 2 | 52 | 2 | 32243781 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 22989184 | ||
| Pubmed | DMXL2 SLF2 TJP1 ZCCHC8 NBEA ZNF227 HNRNPUL1 CMYA5 USPL1 CBS ZNF292 | 2.52e-06 | 1285 | 52 | 11 | 35914814 | |
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 19843512 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 32011705 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 25849321 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 18628683 | ||
| Pubmed | Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina. | 6.57e-06 | 3 | 52 | 2 | 21282647 | |
| Pubmed | Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. | 1.31e-05 | 4 | 52 | 2 | 12669065 | |
| Pubmed | Homodimerization and isoform-specific heterodimerization of neuroligins. | 1.31e-05 | 4 | 52 | 2 | 22671294 | |
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 20579107 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 25369936 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 16077734 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 17292328 | ||
| Pubmed | 1.69e-05 | 102 | 52 | 4 | 10231032 | ||
| Pubmed | Neuroligins and neurexins link synaptic function to cognitive disease. | 2.19e-05 | 5 | 52 | 2 | 18923512 | |
| Pubmed | Synapse formation: if it looks like a duck and quacks like a duck ... | 2.19e-05 | 5 | 52 | 2 | 10996085 | |
| Pubmed | 2.19e-05 | 5 | 52 | 2 | 37865312 | ||
| Pubmed | 3.28e-05 | 6 | 52 | 2 | 21838267 | ||
| Pubmed | 3.28e-05 | 6 | 52 | 2 | 29724786 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 4.34e-05 | 430 | 52 | 6 | 35044719 | |
| Pubmed | 4.69e-05 | 1442 | 52 | 10 | 35575683 | ||
| Pubmed | 5.06e-05 | 268 | 52 | 5 | 33640491 | ||
| Pubmed | Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways. | 6.10e-05 | 8 | 52 | 2 | 30871858 | |
| Pubmed | 7.84e-05 | 9 | 52 | 2 | 23010509 | ||
| Pubmed | Microglia ablation alleviates myelin-associated catatonic signs in mice. | 7.84e-05 | 9 | 52 | 2 | 29252214 | |
| Pubmed | 9.64e-05 | 497 | 52 | 6 | 23414517 | ||
| Pubmed | 9.79e-05 | 10 | 52 | 2 | 19506036 | ||
| Pubmed | 1.20e-04 | 11 | 52 | 2 | 32973045 | ||
| Pubmed | 1.20e-04 | 11 | 52 | 2 | 26403076 | ||
| Pubmed | 1.33e-04 | 329 | 52 | 5 | 17474147 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 1.62e-04 | 1353 | 52 | 9 | 29467282 | |
| Pubmed | Advancing the understanding of autism disease mechanisms through genetics. | 1.69e-04 | 13 | 52 | 2 | 27050589 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 1.91e-04 | 1082 | 52 | 8 | 38697112 | |
| Pubmed | 1.97e-04 | 14 | 52 | 2 | 36706168 | ||
| Pubmed | 2.27e-04 | 15 | 52 | 2 | 18227507 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 2.40e-04 | 588 | 52 | 6 | 38580884 | |
| Pubmed | 2.60e-04 | 16 | 52 | 2 | 10932191 | ||
| Pubmed | 2.60e-04 | 16 | 52 | 2 | 20978075 | ||
| Pubmed | 2.60e-04 | 16 | 52 | 2 | 23610556 | ||
| Pubmed | 2.66e-04 | 83 | 52 | 3 | 28794006 | ||
| Pubmed | 2.94e-04 | 17 | 52 | 2 | 11781569 | ||
| Pubmed | HSPB7 is indispensable for heart development by modulating actin filament assembly. | 3.30e-04 | 18 | 52 | 2 | 29078393 | |
| Pubmed | 4.19e-04 | 653 | 52 | 6 | 22586326 | ||
| Pubmed | 4.88e-04 | 102 | 52 | 3 | 26584622 | ||
| Pubmed | 4.94e-04 | 1247 | 52 | 8 | 27684187 | ||
| Pubmed | Regulation of Hematopoiesis and Methionine Homeostasis by mTORC1 Inhibitor NPRL2. | 4.97e-04 | 22 | 52 | 2 | 26166573 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 5.22e-04 | 954 | 52 | 7 | 36373674 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 5.26e-04 | 444 | 52 | 5 | 34795231 | |
| Pubmed | 5.31e-04 | 105 | 52 | 3 | 9628581 | ||
| Pubmed | TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation. | 5.92e-04 | 109 | 52 | 3 | 33554859 | |
| Pubmed | Large-scale phosphomimetic screening identifies phospho-modulated motif-based protein interactions. | 6.08e-04 | 110 | 52 | 3 | 37219487 | |
| Pubmed | DSCAM Deficiency Leads to Premature Spine Maturation and Autism-like Behaviors. | 6.96e-04 | 26 | 52 | 2 | 34848499 | |
| Pubmed | 8.21e-04 | 122 | 52 | 3 | 30773093 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 8.32e-04 | 281 | 52 | 4 | 28706196 | |
| Pubmed | 8.42e-04 | 493 | 52 | 5 | 15368895 | ||
| Pubmed | 8.77e-04 | 285 | 52 | 4 | 34369648 | ||
| Pubmed | Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. | 8.81e-04 | 125 | 52 | 3 | 32891193 | |
| Pubmed | Role of Elavl-like RNA-binding protein in retinal development and signal transduction. | 9.92e-04 | 31 | 52 | 2 | 39307290 | |
| Pubmed | 9.92e-04 | 31 | 52 | 2 | 22282597 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.02e-03 | 774 | 52 | 6 | 15302935 | |
| Pubmed | 1.05e-03 | 133 | 52 | 3 | 15144186 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 1.23e-03 | 1105 | 52 | 7 | 35748872 | |
| Pubmed | 1.26e-03 | 35 | 52 | 2 | 25343990 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 1.38e-03 | 146 | 52 | 3 | 23892456 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | 1.39e-03 | 552 | 52 | 5 | 10737800 | |
| Pubmed | 1.40e-03 | 147 | 52 | 3 | 26465331 | ||
| Pubmed | 1.46e-03 | 149 | 52 | 3 | 22664934 | ||
| Pubmed | Mutation of ARHGAP9 in patients with coronary spastic angina. | 1.49e-03 | 38 | 52 | 2 | 19911011 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 1.43e-03 | 29 | 35 | 2 | 396 | |
| Coexpression | RAMALHO_STEMNESS_UP | 3.95e-05 | 196 | 51 | 5 | M9473 | |
| Coexpression | GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_DN | 4.35e-05 | 200 | 51 | 5 | M3510 | |
| Coexpression | GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL6_STIM_MACROPHAGE_UP | 4.35e-05 | 200 | 51 | 5 | M6606 | |
| Coexpression | RAMALHO_STEMNESS_UP | 4.66e-05 | 203 | 51 | 5 | MM1017 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 1.63e-06 | 170 | 52 | 5 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|RV / Chamber and Cluster_Paper | 6.96e-06 | 105 | 52 | 4 | 49e16b11f16e83a7d17d162c14bce991201bcc2a | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.26e-05 | 122 | 52 | 4 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.56e-05 | 159 | 52 | 4 | 5ca96db4281abb5f646150ccf36adc66ab201c78 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.62e-05 | 170 | 52 | 4 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.62e-05 | 170 | 52 | 4 | 876b84740e15399bfff2b9c7f0b80fd759bbdb3f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.62e-05 | 170 | 52 | 4 | 1f8738acf439d893880db7e1fdc9b3615ca00c39 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.29e-05 | 176 | 52 | 4 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.65e-05 | 179 | 52 | 4 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.90e-05 | 181 | 52 | 4 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 6.03e-05 | 182 | 52 | 4 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.16e-05 | 183 | 52 | 4 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 6.29e-05 | 184 | 52 | 4 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.29e-05 | 184 | 52 | 4 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.42e-05 | 185 | 52 | 4 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 6.42e-05 | 185 | 52 | 4 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 6.56e-05 | 186 | 52 | 4 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.56e-05 | 186 | 52 | 4 | 26458ff8cad5577de4306cffa0ca69eb26940e0d | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.56e-05 | 186 | 52 | 4 | a71397efc68d2916ddc373d92cfd07be58033e1c | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.69e-05 | 187 | 52 | 4 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.69e-05 | 187 | 52 | 4 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.69e-05 | 187 | 52 | 4 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 6.98e-05 | 189 | 52 | 4 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 7.12e-05 | 190 | 52 | 4 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.12e-05 | 190 | 52 | 4 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 190 | 52 | 4 | 1ab3f19f1ce9f58e5125135704d94655a2e330a0 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.41e-05 | 192 | 52 | 4 | 2cc712186e37fb21a964c032765c36a8b4a852cf | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.56e-05 | 193 | 52 | 4 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | COVID-19-Heart-Mito_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.19e-05 | 197 | 52 | 4 | 44e49943d62bfe622b40ad0460093d31540544df | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.68e-05 | 200 | 52 | 4 | 9169a9ec8e9ab95d90a64c5a19ac666a5cf82313 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_only / Treatment groups by lineage, cell group, cell type | 8.68e-05 | 200 | 52 | 4 | 7c62678cf408aaaf98d6df0fb27814d2007c4521 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf-Oligodendrocyte.Trf.Ctps_(Ctps)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.08e-04 | 79 | 52 | 3 | 239d34f40c3a96186231f3aabd41c4988af3f372 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.08e-04 | 79 | 52 | 3 | a60fcbb278ba629af922c53faf58e4d96c537b15 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.17e-04 | 81 | 52 | 3 | 9ac80b8393182676f061e0e71b8361f5ccba495c | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf-Oligodendrocyte.Trf.Ctps_(Ctps)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.17e-04 | 81 | 52 | 3 | fec374d1ae512f85e2f32620834c0ce2800faecb | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.93e-04 | 96 | 52 | 3 | 7e02df1f28fea1d962f9b1d3835212765a6642cc | |
| Disease | spleen volume | 5.72e-05 | 43 | 51 | 3 | EFO_0600047 | |
| Disease | tumor necrosis factor receptor superfamily member 19L measurement | 8.15e-05 | 8 | 51 | 2 | EFO_0008309 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.40e-04 | 152 | 51 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | platelet crit | 2.12e-04 | 952 | 51 | 8 | EFO_0007985 | |
| Disease | urinary albumin to creatinine ratio | 2.62e-04 | 179 | 51 | 4 | EFO_0007778 | |
| Disease | basophil percentage of granulocytes | 4.05e-04 | 83 | 51 | 3 | EFO_0007995 | |
| Disease | neutrophil percentage of granulocytes | 6.53e-04 | 228 | 51 | 4 | EFO_0007994 | |
| Disease | eosinophil percentage of granulocytes | 7.19e-04 | 234 | 51 | 4 | EFO_0007996 | |
| Disease | Attention deficit hyperactivity disorder | 7.89e-04 | 24 | 51 | 2 | C1263846 | |
| Disease | basophil count, eosinophil count | 8.03e-04 | 241 | 51 | 4 | EFO_0004842, EFO_0005090 | |
| Disease | selenium measurement | 1.15e-03 | 29 | 51 | 2 | EFO_0006331 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 1.39e-03 | 127 | 51 | 3 | EFO_0008595, EFO_0020947 | |
| Disease | Lymphoma, Non-Hodgkin | 1.41e-03 | 32 | 51 | 2 | C0024305 | |
| Disease | Squamous cell carcinoma of lung | 1.41e-03 | 32 | 51 | 2 | C0149782 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.61e-03 | 291 | 51 | 4 | EFO_0008317, EFO_0020946 | |
| Disease | eosinophil percentage of leukocytes | 1.75e-03 | 746 | 51 | 6 | EFO_0007991 | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 1.95e-03 | 307 | 51 | 4 | EFO_0004612, EFO_0020946 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 2.00e-03 | 144 | 51 | 3 | EFO_0004611, EFO_0020943 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 2.24e-03 | 150 | 51 | 3 | EFO_0004611, EFO_0020947 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SHETSQPIPKEEHPT | 486 | Q6UY09 | |
| KTPPHPSIEDVKVHT | 2241 | Q8TDJ6 | |
| HHPDKNPDDPAATEK | 46 | Q9UF47 | |
| VPVHQHSPSEPFLEK | 551 | Q9P2D1 | |
| KIVPSHHDPSEKTGE | 21 | Q8WWL7 | |
| KPPEDKPEDVHTSHP | 346 | Q5RL73 | |
| KDLLKHTPEDHPDHP | 1221 | Q96PE2 | |
| ADPPKTHVTHHPVFD | 206 | P17693 | |
| VSHLCPEPPEKDVSH | 471 | Q5HY64 | |
| VKFDPPLRKETEPHH | 336 | Q8IVH8 | |
| YPHEVPDSKPSDHLK | 2671 | Q8IWI9 | |
| HDEHSCPFKKSKPHP | 351 | O60291 | |
| EIPASPFHIKVDPSH | 851 | Q14315 | |
| PFHIKVDPSHDASKV | 856 | Q14315 | |
| TAEPHSTPGHPVKKE | 191 | Q8IX07 | |
| DTASKAPKDPPESHS | 416 | C9JSJ3 | |
| NPKHSKDPHKTGPED | 646 | Q8NFZ3 | |
| HLTHFKPLTPDQDEP | 26 | Q9Y2I7 | |
| SSTAKPEVEHPEPDH | 76 | Q9NZI5 | |
| NRPHAPHSPIKFSEK | 111 | P52797 | |
| DKHSHKPHPVETSQP | 361 | Q03188 | |
| EKEAHRSTPPFPEEK | 2086 | Q8N3K9 | |
| FQSKGEHDHPKPETK | 146 | Q9NP62 | |
| HHTAPAKSPKILPDI | 66 | P35520 | |
| EPSHSVKVHTVPKPG | 181 | O95260 | |
| QIPDHPKHFSIHPDT | 286 | Q08554 | |
| HSTPDSPAKPEKNGH | 316 | P14416 | |
| SHSPKVKEDLPHTAP | 346 | Q99500 | |
| NPKHSKDPHKTGPED | 646 | Q8N0W4 | |
| EISVKHLPSTEPDPH | 266 | Q9BUJ2 | |
| SHEVVPDHLRTKPDP | 101 | Q96G25 | |
| EKPHPHEEATTLPEE | 461 | A4FU49 | |
| HPDPKALKGFHTDPE | 336 | Q6ZQX7 | |
| HTDPEALKGFHPDPK | 346 | Q6ZQX7 | |
| VHKPHPEPDSTVKIQ | 826 | Q8NFP9 | |
| IEHFVDPSEKDHPKF | 351 | P41250 | |
| KKFSVTIDAIPDHHP | 726 | Q8IX21 | |
| TLFTHPPKDEKAPHL | 136 | Q8NEG4 | |
| ATSQEHSESKDPPPK | 551 | P51825 | |
| KSAEEKAEHPKAPHP | 191 | Q53QW1 | |
| KAEHPKAPHPEAEAL | 196 | Q53QW1 | |
| HEKPDSENVPPSKHH | 176 | Q9Y2H5 | |
| SPDLEECHTPHKPQK | 91 | Q5W0Q7 | |
| FDHPEESIPKPVHTR | 16 | Q6NZY4 | |
| HPKTPESAPENKDSE | 1616 | Q96T58 | |
| KPPPSATDVSFHKEN | 691 | Q6ZQN7 | |
| PKDHLLHGPETSSDK | 781 | Q6ZQQ2 | |
| KHLDDHSTPPEKVLP | 826 | O60281 | |
| FVEPSSEHPLSHKPE | 341 | Q5T1R4 | |
| DPDSAKPEKTHPHDA | 161 | Q8IUG5 | |
| KPEKTHPHDAPPCKT | 166 | Q8IUG5 | |
| AVSTPVKHADDHTPK | 351 | Q07157 | |
| SPFHEHIKTDTEPKP | 211 | Q86WZ6 | |
| PKEYPHSAKDEAHPV | 646 | Q96MT1 | |
| LEHSSPEKEAPSPEK | 1111 | Q13459 | |
| SHEHKFPTVPVKSEL | 1236 | P52179 |